Connect Biopharma Holdings Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -32.3% | -46.0% | +4.5% | -6.0% | -1.2% | +4.7% | +1.1% | -9.4% | -12.2% | – | |
| – | – | – | +6.8% | -38.8% | +141.8% | -80.7% | +1.0% | -3.7% | +0.1% | +30.8% | +28.7% | – | |
| – | – | – | -260.4% | – | – | -124.1% | – | – | – | -27.9% | -102.8% | – | |
| – | -100.0% | – | +5,134.1% | -66.3% | +112.3% | -74.0% | +274.1% | -88.8% | -52.9% | -100.0% | – | – | |
| – | – | – | -69.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | -99.3% | +7,950.0% | +33.5% | +232.6% | +2,364.6% | +7.5% | – | |
| – | – | – | – | -143.6% | – | – | – | – | – | +1,437.8% | -247.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.